Results 161 to 170 of about 19,792 (277)

Studies on Hypolipidemic Agents. II. Syntheses and Hypolipidemic Activities of Phenoxyacetylinosine Derivatives

YAKUGAKU ZASSHI, 1974
FUMIHIKO MIYOSHI, KATSUYUKI HIRAOKA, MITSURU HIROHASHI, KOICHIRO NAGAO, EIICHI SAKAKIBARA   +4 more
openaire   +2 more sources

Food Minor Bioactive Compounds of Polyphenolic and Polyprenolic Nature Are Promising Agents for the Prevention and Therapy of Non-Alcoholic Fatty Liver Disease. [PDF]

Molecules
Balakina A, Sidorova Y, Petrov N, Shipelin V.   +3 more
europepmc   +1 more source

Studies on hypolipidemic agents. I. Synthesis and pharmacological properties of nicotinic acid-ethanolamine derivatives.

, 1983
KUNIO SEKI, TAKEHIKO YAMASHITA, JUNICHI ISEGAWA, Minoru Fukuda, Hiroshi Shimamura, M. OHKI   +5 more
openalex   +2 more sources

Epicardial Adipose Tissue: A Potential Target to Improve Left Ventricular Diastolic Dysfunction. [PDF]

Rev Cardiovasc Med
Ran CQ, He WT.
europepmc   +1 more source

Use of Complementary and Alternative Medicines (CAMs) among type 2 diabetes patients in Sri Lanka: a cross sectional survey [PDF]

, 2014

core   +1 more source

Innovative methods in evaluating the effects of lipid-lowering medication on bone tissue. [PDF]

Sci Rep
Moldovan I, Fechete R, Bîrla A, Orban E, Sipos RS.   +4 more
europepmc   +1 more source

Noninvasive Evaluation of Abdominal Fat and Liver Changes Following Progressive Weight Loss in Severely Obese Patients Treated with Laparoscopic Gastric Bypass. [PDF]

, 2009
Alfonsi L, CONTALDO, FRANCO, De Sio I, Del Genio F, Del Genio G, FINELLI, CARMINE, MARRA, MAURIZIO, PASANISI, FABRIZIO   +7 more
core   +1 more source

Studies on Hypolipidemic Agents. I. Syntheses and Hypolipidemic Activities of 2-(4'-Chlorophenoxy) isobutyric Acid Derivatives

, 1974
Fumihiko Miyoshi, Hisao Kuroda, KATSUYUKI HIRAOKA, HIDEO FUKAMI, KUNIO ONISHI, Masaru Mori, KOICHIRO NAGAO, MUNEYOSHI SHIGA, Eiichi Sakakibara   +8 more
openalex   +2 more sources

Fenofibrate and Diabetic Retinopathy. [PDF]

Diabetes Ther
Parra-Pineda A, Lizarazo-Bocanegra S, Villalba-Montero LF, Ayala-Quintero CC, Losada-Díaz F, Correa-Osio I, Lizarazo-Rojas LA, Mendivil CO.   +7 more
europepmc   +1 more source

Effect of Statins and PCSK9 Inhibition on Metabolic Dysfunction-Associated Steatotic Liver Disease. [PDF]

J Dig Dis
Theocharidou E, Gossios T.
europepmc   +1 more source